Who owns Rigel Pharmaceuticals?

Key details on Rigel Pharmaceuticals (Ticker: RIGL)

Who owns Rigel Pharmaceuticals?

Is RIGL a good stock to own? Find out who bought Rigel Pharmaceuticals, who sold Rigel Pharmaceuticals (RIGL) stock, and who holds a large position in Rigel Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 13.17M $25.55M Sept. 30, 2014
Broadfin Capital 8.50M $19.30M Dec. 31, 2014
Palo Alto Investors 5.18M $11.75M Dec. 31, 2014
OppenheimerFunds 5.00M $11.35M Dec. 31, 2014
Wellington Management Company 4.92M $11.16M Dec. 31, 2014
T. Rowe Price Associates 4.61M $16.51M Sept. 30, 2013
BlackRock Institutional Trust Company, N.A. 3.27M $7.41M Dec. 31, 2014
NEA Management Company 3.24M $7.36M Dec. 31, 2014
Vanguard 2.99M $6.80M Dec. 31, 2014
BVF 2.58M $10.00M March 31, 2014
BlackRock Fund Advisors 2.40M $5.46M Dec. 31, 2014
Deerfield Management Company 2.40M $5.44M Dec. 31, 2014
STATE STREET CORPORATION 2.27M $14.74M Dec. 31, 2013
SENZAR ASSET MANAGEMENT 2.12M $4.81M Dec. 31, 2014
Visium Asset Management 2.01M $5.73M Dec. 31, 2013
HealthCor Management 2.00M $15.78M Dec. 31, 2011
Millennium Management 1.97M $4.47M Dec. 31, 2014
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.95M $4.44M Dec. 31, 2014